Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
104,986,330
-
Total 13F shares
-
71,864,949
-
Share change
-
-797,123
-
Total reported value
-
$32,130,149,743
-
Put/Call ratio
-
115%
-
Price per share
-
$447.12
-
Number of holders
-
590
-
Value change
-
-$383,636,432
-
Number of buys
-
284
-
Number of sells
-
262
Institutional Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q3 2017
As of 30 Sep 2017,
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) was held by
590 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
71,864,949 shares.
The largest 10 holders included
FMR LLC, Capital World Investors, BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, SANDS CAPITAL MANAGEMENT, LLC, LOOMIS SAYLES & CO L P, BANK OF AMERICA CORP /DE/, and JANUS HENDERSON GROUP PLC.
This page lists
594
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.